Praxis Precision Medicines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRAX and other ETFs, options, and stocks.About PRAX
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus.
CEOMarcio Souza
CEOMarcio Souza
Employees116
Employees116
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2015
Founded2015
Employees116
Employees116
PRAX Key Statistics
Market cap6.65B
Market cap6.65B
Price-Earnings ratio-20.60
Price-Earnings ratio-20.60
Dividend yield—
Dividend yield—
Average volume1.03M
Average volume1.03M
High today—
High today—
Low today—
Low today—
Open price$270.72
Open price$270.72
Volume0.00
Volume0.00
52 Week high$282.99
52 Week high$282.99
52 Week low$26.70
52 Week low$26.70
Stock Snapshot
The current Praxis Precision Medicines(PRAX) stock price is $265.86, with a market capitalization of 6.65B. The stock trades at a price-to-earnings (P/E) ratio of -20.60.
Praxis Precision Medicines(PRAX) stock opened on 2025-12-18 at $270.72. The price climbed to — and dipped to —.
Praxis Precision Medicines(PRAX) shares are trading with a volume of 0, against a daily average of 1.03M.
In the last year, Praxis Precision Medicines(PRAX) shares hit a 52-week high of $282.99 and a 52-week low of $26.70.
In the last year, Praxis Precision Medicines(PRAX) shares hit a 52-week high of $282.99 and a 52-week low of $26.70.
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
0%
Sell
6.7%
People also own
Based on the portfolios of people who own PRAX. This list is generated using Robinhood data, and it’s not a recommendation.